Rare diseases
Investigational molecules
Locations
703 conditions with trials, the busiest first
3 898 trials across Europe, recruiting first
Study on Propranolol and Pembrolizumab for Patients with Advanced Angiosarcoma and Undifferentiated Pleomorphic Sarcoma
DenmarkStudy on the Effect of Post-Surgery Chemotherapy with Irinotecan and Drug Combination for Patients with Colorectal Cancer and Liver Metastases
FranceStudy of Nivolumab for Patients with Metastatic Solid Tumors and Leptomeningeal Disease
GermanyStudy of Meclofenamate Sodium and Temozolomide for Patients with Progressive MGMT-Methylated Glioblastoma
GermanyStudy on Preventing Hypothyroidism in Patients with Medulloblastoma and Pediatric Lymphoma Using Levothyroxine During Radiation Therapy
ItalySafety Monitoring of Crizotinib for Patients Continuing from Previous Studies
ItalyStudy of Atezolizumab After Chemo-radiotherapy for Patients with Muscle-invasive Bladder Cancer Not Eligible for Radical Surgery
FranceStudy on the Safety and Effects of Divarasib with Pembrolizumab and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation
BelgiumStudy on Metronomic Chemotherapy for Children and Teenagers with Relapsed or Refractory Wilms Tumor Using Vincristine, Irinotecan, Etoposide, Temozolomide, and Isotretinoin
FranceStudy on Darolutamide and Triptorelin for Patients with Localized High-Risk Prostate Cancer
FranceStudy on Atezolizumab, Bevacizumab, and EXL01 for Patients with Liver Cancer Not Responding to First-Line Immunotherapy
FranceStudy of Palbociclib and Fulvestrant for Women with Advanced Breast Cancer After Previous CDK4/6 Inhibitor and Hormonal Therapy
ItalyThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
